290 related articles for article (PubMed ID: 25767942)
1. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
2. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
4. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
[TBL] [Abstract][Full Text] [Related]
6. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
7. Fetal growth retardation and second trimester maternal serum human chorionic gonadotrophin levels.
Luckas MJ; Sandland R; Hawe J; Neilson JP; McFadyen IR; Meekins JW
Placenta; 1998; 19(2-3):143-7. PubMed ID: 9548180
[TBL] [Abstract][Full Text] [Related]
8. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
9. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
10. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
11. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
12. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
Lepage N; Chitayat D; Kingdom J; Huang T
Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth.
Celik E; Melekoğlu R; Baygül A; Kalkan U; Şimşek Y
J Obstet Gynaecol; 2022 Aug; 42(6):1956-1961. PubMed ID: 35620869
[TBL] [Abstract][Full Text] [Related]
14. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
[TBL] [Abstract][Full Text] [Related]
15. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
Waller DK; Lustig LS; Cunningham GC; Feuchtbaum LB; Hook EB
Obstet Gynecol; 1996 Nov; 88(5):816-22. PubMed ID: 8885920
[TBL] [Abstract][Full Text] [Related]
16. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
Hershkovitz R; de Swiet M; Kingdom J
Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599
[TBL] [Abstract][Full Text] [Related]
17. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein.
Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
Obstet Gynecol; 1997 May; 89(5 Pt 1):666-70. PubMed ID: 9166297
[TBL] [Abstract][Full Text] [Related]
18. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening.
Bartkute K; Balsyte D; Wisser J; Kurmanavicius J
J Perinat Med; 2017 Oct; 45(7):817-820. PubMed ID: 27771626
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Räty R; Koskinen P; Alanen A; Irjala K; Matinlauri I; Ekblad U
Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
